Advertorial

#Advertorial #Epigenomics #Genomics #Mutliomics #Neurological disease #Sampled

From genomics to multiomics: A broader view of neurological disease

In this paid-for advertorial for the Fall 2026 issue of DDW, Sampled shares insight on neurological disease with a genomics and multiomics lens.  Genomic testing can identify drivers of neurological disease, but many variants remain difficult to interpret. Multiomics helps to close this gap by connecting genetic findings with… Read More

#Exclusive Content

Containers in a biobank
#Advertorial #Biobanking #Genetics / genomics

Storing potential: How biobanking powers medicine

This paid-for advertorial by Sampled appeared in DDW Volume 26 – Issue 3, Summer 2025 Read the digital issue Biobanking optimises sample storage, processing, transport, and access to deliver the promises of medical innovation. Biobanks are designed to meet the demands of new medical technologies by offering the scale… Read More

#Exclusive Content

Lab mouse
#Advertorial #Animal models #Drug discovery #Mouse models

Advancing drug discovery through next-generation mouse models

This advertorial for Taconic appeared in DDW Volume 26 – Issue 2, Spring 2025 Read the digital issue Taconic in vivo models provide enhanced physiological relevance for translational research. The NOG portfolio offers severely immunodeficient mice enabling engraftment of human hematopoietic stem cells (HSCs) to recapitulate features of the… Read More

#Exclusive Content

Heart in a box
#3D cell culture #Advertorial #Biosafety testing #Cell Science #In vitro assays

Ncyte Heart in a Box: Human iPSC-derived 3D cardiac microtissue

This advertorial for Ncardia appeared in DDW Volume 26 – Issue 2, Spring 2025 Read the digital issue When hearts are on the line, accuracy is vital.  Ncyte® Heart in a Box™ is a high-purity, high-functional cell product that mirrors the human heart’s complexity in vitro, giving you… Read More

#Exclusive Content

Next generation sequencing
#Advertorial #Drug discovery #Next generation sequencing

How fast nucleic acid quantification and purity assessment support NGS

This advertorial for BMG Labtech appeared in DDW Volume 26 – Issue 1, Winter 2024/25 Read the digital issue Next generation sequencing (NGS) is driving advances in the life sciences including the detection of disease-causing mutations. However, the downstream quantification of nucleic acids and purity assessment remain vital for success. Read More

#Exclusive Content

Human cells
#Advertorial #Cell line development #Picodroplet technology #Single-cell analysis #Sphere Fluidics

Accelerating biopharmaceutical discovery with single-cell analysis

This paid-for advertorial by Sphere Fluidics appeared in DDW Volume 25 – Issue 2, Spring 2024. Sphere Fluidics discusses how picodroplet microfluidic technology and automated single-cell analysis can help overcome barriers to accelerating biopharmaceutical discovery and cell line development workflows. Challenges in cell line development    Biopharmaceutical development is a time-consuming… Read More

#Exclusive Content

Medicinal cannabis
#Advertorial #BMG Labtech #Cannabinoid #Medicinal cannabis #Microplate readers

How microplate readers can support cannabinoid research

This paid-for advertorial by BMG Labtech appeared in DDW Volume 25 – Issue 2, Spring 2024. Cannabinoid research has gained significant attention in recent years, as scientists have been exploring the potential therapeutic benefits of these compounds. From studying their role in treating neurological disorders to pain management, this field of… Read More

#Exclusive Content

#Advertorial #Astrea Bioseparations #Bioprocessing #Cell and gene therapy #Nanofiber technology

Nanofiber technology enabling the future of CGT bioprocessing

This paid-for advertorial by Astrea Bioseparations appeared in DDW Volume 24 – Issue 1, Winter 2022/2023 – Cell and Gene Therapy Guide. Therapeutic developers face significant challenges in purifying cell and gene therapy (CGT) modalities. Current processes rely on solutions developed for monoclonal antibodies that are not fit for purpose… Read More

#Exclusive Content